Accelerated Approval: Withdrawing Gene Therapies Could Be Easier Than Small Molecules
Executive Summary
The FDA would only withdraw a rare disease gene therapy for “pretty clear” reasons, such as when there is minimal benefit with extensive side effects. The one-and-done nature of administration also makes withdrawal easier, CBER Director Peter Marks says.